/People

Scott Gottlieb

Investor

Partner at New Enterprise Associates (NEA)

Chevy Chase, Maryland

Writes $2M – $50M checks · typically $25M

Find your path to Scott

Sign up to see every warm intro you have to Scott

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Scott. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Beyond investing

Education
Studied at Wesleyan University (BA, economics) Studied at Icahn School of Medicine at Mount Sinai (MD)
Boards
Gottlieb was a member of the policy board of the Leukemia & Lymphoma Society.
Communities
Gottlieb is a contributor to CNBC and the CBS News program Face the Nation. Gottlieb served on the Federal Health Information Technology Policy Committee, which advises the U.S. Department of Health and Human Services.
Awards
Gottlieb is an elected member of the National Academy of Medicine.
Family
Gottlieb grew up in East Brunswick, New Jersey, the son of Stanley, a psychiatrist, and Marsha Gottlieb, a schoolteacher, and his family is Jewish.

From published sources — common ground for a warm intro.

Investments

Board seats

American Pathology PartnersBravo HealthDaiichi Sankyo Inc.Illumina, Inc.Kure Corp.Pfizer, IncTempusTolero PharmaceuticalsUnitedHealth Group

Sources: curated public sources · SEC Form D filings.

Colleagues at New Enterprise Associates (NEA)

Frequently asked questions

Who is Scott Gottlieb?
Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.
Where does Scott Gottlieb work?
Scott Gottlieb is Partner at New Enterprise Associates (NEA).
What does Scott Gottlieb invest in?
Scott Gottlieb invests in AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
What check size does Scott Gottlieb write?
Scott Gottlieb typically writes checks of $2M – $50M.
What boards does Scott Gottlieb sit on?
Scott Gottlieb holds tracked board seats at American Pathology Partners, Bravo Health, Daiichi Sankyo Inc., Illumina, Inc., Kure Corp., Pfizer, Inc, Tempus, Tolero Pharmaceuticals, UnitedHealth Group.
What companies has Scott Gottlieb invested in?
Investments tracked here include Aetion, Comanche Biopharma, Resilience, Tempus, Xaira Therapeutics.
What awards has Scott Gottlieb received?
Gottlieb is an elected member of the National Academy of Medicine.

About this profile. Compiled from public sources — New Enterprise Associates (NEA)'s own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights